Press Releases News Year None202020192018201720162015201420132012 IVERIC bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Oct 02, 2020 | IVERIC bio to Participate in Upcoming September Investor / Industry Conferences Sep 03, 2020 | IVERIC bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Sep 02, 2020 | IVERIC bio Announces Publication of GATHER1 Phase 3 Clinical Trial Results for Zimura® in Geographic Atrophy Secondary to Age-related Macular Degeneration, in Ophthalmology®, the Journal of the American Academy of Ophthalmology Sep 01, 2020 | IVERIC bio Reports Second Quarter 2020 Operational Highlights and Financial Results Aug 05, 2020 | IVERIC bio to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference Aug 04, 2020 | IVERIC bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Aug 03, 2020 | IVERIC bio to Report Second Quarter 2020 Financial Results and Host Conference Call on Wednesday, August 5, 2020 Jul 29, 2020 | IVERIC bio Announces the Addition of Mark S. Blumenkranz, M.D., M.M.S., to its Board of Directors Jul 16, 2020 | IVERIC bio Announces First Patient Dosed in Second Zimura® Phase 3 Clinical Trial for the Treatment of Geographic Atrophy Secondary to Age-Related Macular Degeneration Jun 30, 2020 | Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »
IVERIC bio Announces Publication of GATHER1 Phase 3 Clinical Trial Results for Zimura® in Geographic Atrophy Secondary to Age-related Macular Degeneration, in Ophthalmology®, the Journal of the American Academy of Ophthalmology Sep 01, 2020 |
IVERIC bio to Report Second Quarter 2020 Financial Results and Host Conference Call on Wednesday, August 5, 2020 Jul 29, 2020 |
IVERIC bio Announces the Addition of Mark S. Blumenkranz, M.D., M.M.S., to its Board of Directors Jul 16, 2020 |
IVERIC bio Announces First Patient Dosed in Second Zimura® Phase 3 Clinical Trial for the Treatment of Geographic Atrophy Secondary to Age-Related Macular Degeneration Jun 30, 2020 |
Press Releases News Year None202020192018201720162015201420132012 IVERIC bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Oct 02, 2020 | IVERIC bio to Participate in Upcoming September Investor / Industry Conferences Sep 03, 2020 | IVERIC bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Sep 02, 2020 | IVERIC bio Announces Publication of GATHER1 Phase 3 Clinical Trial Results for Zimura® in Geographic Atrophy Secondary to Age-related Macular Degeneration, in Ophthalmology®, the Journal of the American Academy of Ophthalmology Sep 01, 2020 | IVERIC bio Reports Second Quarter 2020 Operational Highlights and Financial Results Aug 05, 2020 | IVERIC bio to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference Aug 04, 2020 | IVERIC bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Aug 03, 2020 | IVERIC bio to Report Second Quarter 2020 Financial Results and Host Conference Call on Wednesday, August 5, 2020 Jul 29, 2020 | IVERIC bio Announces the Addition of Mark S. Blumenkranz, M.D., M.M.S., to its Board of Directors Jul 16, 2020 | IVERIC bio Announces First Patient Dosed in Second Zimura® Phase 3 Clinical Trial for the Treatment of Geographic Atrophy Secondary to Age-Related Macular Degeneration Jun 30, 2020 | Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »
IVERIC bio Announces Publication of GATHER1 Phase 3 Clinical Trial Results for Zimura® in Geographic Atrophy Secondary to Age-related Macular Degeneration, in Ophthalmology®, the Journal of the American Academy of Ophthalmology Sep 01, 2020 |
IVERIC bio to Report Second Quarter 2020 Financial Results and Host Conference Call on Wednesday, August 5, 2020 Jul 29, 2020 |
IVERIC bio Announces the Addition of Mark S. Blumenkranz, M.D., M.M.S., to its Board of Directors Jul 16, 2020 |
IVERIC bio Announces First Patient Dosed in Second Zimura® Phase 3 Clinical Trial for the Treatment of Geographic Atrophy Secondary to Age-Related Macular Degeneration Jun 30, 2020 |
